Laboratory Medicine ›› 2023, Vol. 38 ›› Issue (11): 1052-1056.DOI: 10.3969/j.issn.1673-8640.2023.11.009
Previous Articles Next Articles
WU Ying1, ZHANG Lihong2, GAO Yin2()
Received:
2022-05-14
Revised:
2023-03-23
Online:
2023-11-30
Published:
2024-01-10
CLC Number:
WU Ying, ZHANG Lihong, GAO Yin. Predictive value of high-density lipoprotein cholesterol on the risk of cerebral ischemic stroke in type 2 diabetes mellitus patients[J]. Laboratory Medicine, 2023, 38(11): 1052-1056.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2023.11.009
组别 | 例数 | 病程/年 | 高血压史/ [例(%)] | 吸烟史/ [例(%)] | 收缩压/kPa | 舒张压/kPa | FPG/(mmol/L) | HbA1c/% | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
对照组 | 150 | 8.0(4.0,12.0) | 59(39.3) | 59(39.3) | 17.4±1.9 | 10.9±1.5 | 8.6±2.3 | 8.18±1.79 | |||||||||
CIS组 | 148 | 9.0(4.5,13.5) | 77(52.0) | 60(40.5) | 18.1±11.3 | 11.3±1.5 | 8.8±2.6 | 8.98±1.88 | |||||||||
统计值 | -0.075 | 4.838 | 0.045 | -3.071 | -2.241 | -0.407 | -3.762 | ||||||||||
P值 | 0.940 | 0.028 | 0.832 | 0.002 | 0.026 | 0.684 | <0.001 | ||||||||||
组别 | TG/HDL-C比值 | TC/ (mmol/L) | TG/ (mmol/L) | Hcy/ (mmol/L) | CRP/ (mg/L) | HDL-C/(mmol/L) | LDL-C/(mmol/L) | ||||||||||
对照组 | 1.66(0.83,2.49) | 4.4±1.4 | 2.07(3.10,3.11) | 12.4±3.7 | 5.2±2.4 | 1.4±0.8 | 2.7±0.9 | ||||||||||
CIS组 | 2.32(1.11,3.33) | 4.3±0.9 | 2.86(1.43,4.29) | 14.5±5.7 | 9.6±4.7 | 1.1±0.3 | 2.6±0.9 | ||||||||||
统计值 | -3.776 | 0.732 | -3.305 | -3.777 | -10.197 | 4.275 | -1.539 | ||||||||||
P值 | <0.001 | 0.465 | 0.001 | <0.001 | <0.001 | <0.001 | 0.125 | ||||||||||
组别 | SAA/apo A1比值 | UA/ (mmol/L) | Cr/ (mmol/L) | NEUT#/(×109/L) | PLT/ (×109/L) | AST/ (U/L) | ALT/ (U/L) | non-HDL-C/(mmol/L) | |||||||||
对照组 | 4.58(3.66,5.88) | 251.8±74.8 | 66.6±16.3 | 3.8±1.8 | 207.6±63.8 | 18.5±5.3 | 21.3±6.1 | 3.8±1.1 | |||||||||
CIS组 | 6.65(5.49,12.80) | 253.8±10.5 | 64.3±15.8 | 3.9±1.6 | 203.8±61.7 | 17.7±5.7 | 20.7±5.4 | 4.2±0.9 | |||||||||
统计值 | -3.376 | -0.322 | 1.237 | -0.507 | 0.523 | 1.255 | 0.899 | 3.438 | |||||||||
P值 | <0.001 | 0.748 | 0.217 | 0.613 | 0.601 | 0.210 | 0.369 | 0.001 |
组别 | 例数 | 病程/年 | 高血压史/ [例(%)] | 吸烟史/ [例(%)] | 收缩压/kPa | 舒张压/kPa | FPG/(mmol/L) | HbA1c/% | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
对照组 | 150 | 8.0(4.0,12.0) | 59(39.3) | 59(39.3) | 17.4±1.9 | 10.9±1.5 | 8.6±2.3 | 8.18±1.79 | |||||||||
CIS组 | 148 | 9.0(4.5,13.5) | 77(52.0) | 60(40.5) | 18.1±11.3 | 11.3±1.5 | 8.8±2.6 | 8.98±1.88 | |||||||||
统计值 | -0.075 | 4.838 | 0.045 | -3.071 | -2.241 | -0.407 | -3.762 | ||||||||||
P值 | 0.940 | 0.028 | 0.832 | 0.002 | 0.026 | 0.684 | <0.001 | ||||||||||
组别 | TG/HDL-C比值 | TC/ (mmol/L) | TG/ (mmol/L) | Hcy/ (mmol/L) | CRP/ (mg/L) | HDL-C/(mmol/L) | LDL-C/(mmol/L) | ||||||||||
对照组 | 1.66(0.83,2.49) | 4.4±1.4 | 2.07(3.10,3.11) | 12.4±3.7 | 5.2±2.4 | 1.4±0.8 | 2.7±0.9 | ||||||||||
CIS组 | 2.32(1.11,3.33) | 4.3±0.9 | 2.86(1.43,4.29) | 14.5±5.7 | 9.6±4.7 | 1.1±0.3 | 2.6±0.9 | ||||||||||
统计值 | -3.776 | 0.732 | -3.305 | -3.777 | -10.197 | 4.275 | -1.539 | ||||||||||
P值 | <0.001 | 0.465 | 0.001 | <0.001 | <0.001 | <0.001 | 0.125 | ||||||||||
组别 | SAA/apo A1比值 | UA/ (mmol/L) | Cr/ (mmol/L) | NEUT#/(×109/L) | PLT/ (×109/L) | AST/ (U/L) | ALT/ (U/L) | non-HDL-C/(mmol/L) | |||||||||
对照组 | 4.58(3.66,5.88) | 251.8±74.8 | 66.6±16.3 | 3.8±1.8 | 207.6±63.8 | 18.5±5.3 | 21.3±6.1 | 3.8±1.1 | |||||||||
CIS组 | 6.65(5.49,12.80) | 253.8±10.5 | 64.3±15.8 | 3.9±1.6 | 203.8±61.7 | 17.7±5.7 | 20.7±5.4 | 4.2±0.9 | |||||||||
统计值 | -3.376 | -0.322 | 1.237 | -0.507 | 0.523 | 1.255 | 0.899 | 3.438 | |||||||||
P值 | <0.001 | 0.748 | 0.217 | 0.613 | 0.601 | 0.210 | 0.369 | 0.001 |
自变量 | β值 | 标准误 | Wald值 | OR①值(95%CI②) | P值 |
---|---|---|---|---|---|
HDL-C | -1.042 | 0.332 | 9.861 | 0.353(0.184~0.676) | 0.002 |
non-HDL-C | 1.447 | 0.426 | 11.521 | 4.255(1.842~9.804) | 0.001 |
TG/HDL-C比值 | 0.898 | 0.382 | 5.517 | 2.457(1.160~5.181) | 0.019 |
SAA/apo A1比值 | 1.436 | 0.930 | 13.539 | 4.202(1.957~9.009) | <0.001 |
HbA1c | 2.905 | 0.843 | 11.873 | 18.182(3.497~45.637) | 0.001 |
合并高血压 | 2.113 | 0.409 | 26.716 | 8.264(3.717~18.519) | <0.001 |
年龄 | 1.988 | 0.656 | 9.192 | 7.299(2.020~26.316) | 0.002 |
自变量 | β值 | 标准误 | Wald值 | OR①值(95%CI②) | P值 |
---|---|---|---|---|---|
HDL-C | -1.042 | 0.332 | 9.861 | 0.353(0.184~0.676) | 0.002 |
non-HDL-C | 1.447 | 0.426 | 11.521 | 4.255(1.842~9.804) | 0.001 |
TG/HDL-C比值 | 0.898 | 0.382 | 5.517 | 2.457(1.160~5.181) | 0.019 |
SAA/apo A1比值 | 1.436 | 0.930 | 13.539 | 4.202(1.957~9.009) | <0.001 |
HbA1c | 2.905 | 0.843 | 11.873 | 18.182(3.497~45.637) | 0.001 |
合并高血压 | 2.113 | 0.409 | 26.716 | 8.264(3.717~18.519) | <0.001 |
年龄 | 1.988 | 0.656 | 9.192 | 7.299(2.020~26.316) | 0.002 |
[1] |
PETERS S A, HUXLEY R R, WOODWARD M. Diabetes as a risk factor for stroke in women compared with men:a systematic review and meta analysis of 64 cohorts,including 775 385 individuals and 12 539 strokes[J]. Lancet, 2014, 383(9933):1973-1980.
DOI URL |
[2] |
WANG D, LIU J, LIU M, et al. Patterns of stroke between university hospitals and nonuniversity hospitals in mainland China:prospective multicenter hospital based registry study[J]. World Neurosurg, 2017, 98:258-265.
DOI URL |
[3] |
HU G, PAN Y, WANG M, et al. Inverse association between high-density lipoprotein cholesterol and adverse outcomes among acute ischemic stroke patients with diabetes mellitus[J]. Biomedicines, 2021, 9(12):1947.
DOI URL |
[4] |
MAI W, LIU H, CHEN L, et al. Low HDL-C levels are associated with cervicocerebral atherosclerotic stenosis in Southern Chinese patients with large artery atherosclerotic ischemic stroke[J]. Clinical Neurology and Neurosurgery, 2018, 171:79-84.
DOI PMID |
[5] | 俞联春, 周君玲. 血糖、血脂在老年人群5年内心脑血管疾病发病风险评估中的作用[J]. 检验医学, 2022, 37(4):370-373. |
[6] |
KAZE A D, SANTHANAM P, MUSANI S K, et al. Metabolic dyslipidemia and cardiovascular outcomes in type 2 diabetes mellitus:findings from the look AHEAD study[J]. J Am Heart Assoc, 2021, 10(7):e016947.
DOI URL |
[7] | 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华糖尿病杂志, 2021, 13(4):315-409. |
[8] | 《中国急性缺血性脑卒中诊治指南2018》发布[J]. 中华医学信息导报, 2018, 33(19):10. |
[9] | 邹琼, 杨春祥, 蔡谋善. 脑脉泰对皮质下缺血性脑血管病患者认知、脑白质结构MRI影像的影响[J]. 医学临床研究, 2017, 34(8) :1575-1577. |
[10] | 谭琳琳, 常靖. 脑卒中合并糖尿病的危险因素分析[J]. 河南医学研究, 2018, 27(8) :1411-1413. |
[11] |
MITSIOS J P, EKINCI E I, MITSIOS G P, et al. Relationship between glycated hemoglobin and stroke risk:a systematic review and meta-analysis[J]. J Am Heart Assoc, 2018, 7(11):e007858.
DOI URL |
[12] |
GIMENES R, GIMENES C, ROSA C M, et al. Influence of apocynin on cardiac remodeling in rats with streptozotocin-induced diabetes mellitus[J]. Cardiovasc Diabetol, 2018, 17(1):15.
DOI PMID |
[13] |
TALL A R. Plasma high density lipoproteins:therapeutic targeting and links to atherogenic inflammation[J]. Atherosclerosis, 2018, 276:39-43.
DOI URL |
[14] |
CHATTERJI P, JOO H, LAHIRI K. Racial/ethnic- and education-related dis-parities in the control of risk factors for cardiovascular disease among individuals with diabetes[J]. Diabetes Care, 2012, 35(2):305-312.
DOI URL |
[15] |
BITLA R, NARESH S, SACHAN A. High-density lipoprotein:quality versus quantity in type 2 diabetes mellitus[J]. J Clin Sci Res, 2019, 8:193-200.
DOI URL |
[16] | 利荣乔. 血清Galectin-3和HDL-C水平检测对急性缺血性脑卒中预后的影响研究[J]. 现代检验医学杂志, 2021, 36(5):128-132. |
[17] |
YOUNG K A, MATURU A, LORENZO C, et al. The triglyceride to high-density lipoprotein cholesterol(TG/HDL-C) ratio as a predictor of insulin resistance,β-cell function,and diabetes in Hispanics and African Americans[J]. J Diabetes Complications, 2019, 33(2):118-122.
DOI URL |
[18] | 姚涛, 田柏淋, 胡丹, 等. 三酰甘油/高密度脂蛋白胆固醇比值与血压正常人群动脉硬化进展的关系[J]. 实用医学杂志, 2018, 34(24):4072-4075. |
[19] | 兰庆站, 高琦, 成士清, 等. 血清淀粉样蛋白A和脂蛋白磷脂酶A2联合同型半胱氨酸检测在急性缺血性脑卒中的诊断价值[J]. 国际检验医学杂志, 2018, 39(16):1980-1982. |
[20] |
MADSEN C M, VARBO A, NORDESTGAARD B G. Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies[J]. Eur Heart J, 2017, 38(32):2478-2486.
DOI PMID |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||